Stay updated on Pembrolizumab in NK/T & EBV+ DLBCL: Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab in NK/T & EBV+ DLBCL: Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab in NK/T & EBV+ DLBCL: Clinical Trial page

  1. Check
    2 days ago
    Change Detected
    Summary
    Added Revision: v3.5.2 and removed Revision: v3.5.0.
    Difference
    0.1%
    Check dated 2026-04-19T13:59:54.000Z thumbnail image
  2. Check
    9 days ago
    No Change Detected
  3. Check
    16 days ago
    No Change Detected
  4. Check
    30 days ago
    Change Detected
    Summary
    Page revision updated to v3.5.0; the previous revision v3.4.3 has been removed.
    Difference
    0.1%
    Check dated 2026-03-21T16:48:30.000Z thumbnail image
  5. Check
    45 days ago
    Change Detected
    Summary
    Revision updated to v3.4.3, replacing the previous revision v3.4.2.
    Difference
    0.1%
    Check dated 2026-03-06T19:19:30.000Z thumbnail image
  6. Check
    67 days ago
    Change Detected
    Summary
    The page shows a minor revision update (Revision: v3.4.2 added; Revision: v3.4.1 removed) and no changes to study details or functionality. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-02-13T12:21:25.000Z thumbnail image
  7. Check
    74 days ago
    Change Detected
    Summary
    Revision updated from v3.4.0 to v3.4.1; this is a minor site maintenance update that does not affect study content or user-facing features. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-02-05T16:48:09.000Z thumbnail image
  8. Check
    96 days ago
    Change Detected
    Summary
    Minor version update from v3.3.3 to v3.3.4 with no changes to study content, eligibility criteria, or page functionality. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-01-15T03:30:05.000Z thumbnail image

Stay in the know with updates to Pembrolizumab in NK/T & EBV+ DLBCL: Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab in NK/T & EBV+ DLBCL: Clinical Trial page.